Vyne Therapeutics Inc (NASDAQ:VYNE)
| 2.57 Delayed Data As of Mar 29 |  -0.06 / -2.28%Today’s Change | 1.99 Today|||52-Week Range 14.22 | -4.81% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $8.5M |
Company Description
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.
Contact Information
VYNE Therapeutics, Inc. 685 Route 202-206 Bridgewater New Jersey 08807 |
Employees
Shareholders
| Other institutional | 7.78% |
| Mutual fund holders | 4.74% |
| Individual stakeholders | 1.42% |
Top Executives
| David Domzalski | President, Chief Executive Officer & Director |
| Tyler Zeronda | Chief Financial Officer & Treasurer |
| Iain A. Stuart | Chief Scientific Officer |
| Mutya Harsch | Secretary, Chief Legal Officer & General Counsel |
